Medicines

Here you will find the recommendations we have made about the use of individual medicines in Lancashire.

Semaglutide

Brand: Ozempic ®
NICE TA: 
Indication: For the Treatment of Adults with Insufficiently Controlled Type 2 Diabetes
Disease category: Endocrine system
Commissioning responsibility: CCG
PbR excluded: No

Background

Semaglutide is not a preferred product in the LMMG antihyperglycaemics guideline — the guideline is currently under review.

Semaglutide recommended as an option in line with NICE guideline NG28.

Recommendation

LMMG recommendation: Green
Click here to find the definitions for the colour classifications

Reason for decision:  Suitable for initiation in primary care in line with restrictions (see background paragraph)

Supporting documents:

Semaglutide New Medicine Assessment FINAL (754.4 KiB)

Algorithm For Antihyperglycaemic Therapy In Adults With Type II (Version 1.4) (585.4 KiB)

NICE NG28 - Type 2 diabetes in adults: management

Decisions of Lancashire local decision making groups:

NHS Blackburn With Darwen CCG and NHS East Lancashire CCG NHS Blackpool CCG NHS Chorley and South Ribble CCG and NHS Greater Preston CCG NHS Fylde and Wyre CCG NHS Morecambe Bay CCG NHS West Lancashire CCG

Green

Green

Green

Green

Green

Green